知镜 Cognispect · 医学文献与研究工作台

Administrating Everolimus against neuroendocrine differentiated prostate cancer, a preliminary experience.

Shimomura T, Murakami M, Kasai K, Imai Y, Inaba Y, Kimura T.
The Canadian journal of urology · 2026-10-30 · PMID 43016021

文献摘要

Background Neuroendocrine prostate cancer (NEPC) is a deadly condition, with a median overall survival of less than one year after diagnosis. Although clinical trials are ongoing, an established treatment strategy for NEPC has not yet been developed. A recent clinical trial, RADIANT-4, showed that treatment with everolimus significantly improved survival in patients with progressive neuroendocrine tumors of the lung or gastrointestinal tract. This study evaluated the efficacy of everolimus against neuroendocrine differentiated prostate cancer as an initial investigation. Methods Five patients with neuroendocrine differentiated prostate cancer were treated with everolimus (10 mg daily). In our study, we examined the responses and changes over time of circulating neuroendocrine tumor markers, including neuron-specific enolase (NSE) and pro-gastrin-releasing peptide (pro-GRP). We also evaluated survival outcomes such as castration-resistant prostate cancer (CRPC)-free survival, overall survival (OS), and cancer-specific survival (CSS). Results The median follow-up duration was 32 months. A decline in circulating neuroendocrine tumor markers was observed in all cases. The median decline rate of NSE was -0.417, and that of pro-GRP was -0.647 (p = 0.841). The median CRPC-free survival was 10 months (range: 3-NA). Median CSS and OS were both 32 months (range: 8-NA). Grade 3 adverse events (AEs) included hyperglycemia and pneumonitis. Grade 1 AEs included stomatitis (2 cases), paronychia, and pneumonitis. Conclusions Everolimus demonstrated reductions in circulating neuroendocrine markers in this exploratory cohort of prostate adenocarcinoma with neuroendocrine differentiation; however, these findings are descriptive and do not establish treatment efficacy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。